Pluri Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PLUR research report →
About the company
Pluri Inc. , a biotechnology company established in 2001 and headquartered in Haifa, Israel, specializes in developing innovative placenta-derived cell therapies. Its core mission is to tackle a range of inflammatory conditions, muscle injuries, and hematological disorders.
- CEO
- Yaacov Yanay
- IPO
- 2003
- Employees
- 106
- HQ
- Haifa, IL
Price Chart
- Market Cap
- $18.97M
- P/E
- -0.74
- P/S
- 17.58
- P/B
- -1.14
- EV/EBITDA
- -1.88
- Div Yield
- 0.00%
- Gross Margin
- 19.00%
- Op Margin
- -2412.14%
- Net Margin
- -2424.75%
- ROE
- 203.55%
- ROIC
- -117.79%
- Revenue
- $1.34M · 309.82%
- Net Income
- $-22,583,000 · -8.11%
- EPS
- $-3.56 · 10.78%
- Op Income
- $-22,176,000
- FCF YoY
- -8.10%
- 52W High
- $5.89
- 52W Low
- $1.99
- 50D MA
- $2.69
- 200D MA
- $3.38
- Beta
- 0.63
- Avg Volume
- 10.73K
Get TickerSpark's AI analysis on PLUR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | Manieu Alexandre Weinstein | other | 641 |
| Jun 30, 26 | Manieu Alexandre Weinstein | other | 625,000 |
| Apr 21, 26 | Manieu Alexandre Weinstein | other | 312,500 |
| Apr 21, 26 | Manieu Alexandre Weinstein | other | 312,500 |
| Mar 31, 26 | Manieu Alexandre Weinstein | other | 312,500 |
| Mar 31, 26 | Manieu Alexandre Weinstein | other | 312,500 |
| Dec 8, 25 | Manieu Alexandre Weinstein | other | 625,000 |
| Dec 8, 25 | Manieu Alexandre Weinstein | other | 625,000 |
| Dec 4, 25 | Manieu Alexandre Weinstein | other | 519 |
| Dec 4, 25 | Ajchenbaum Eitan | other | 668 |
Our PLUR coverage
Recent articles, reports, and earnings notes.
No research on PLUR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PLUR report →Similar companies
Peers in the same neighborhood.